PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
04-Jul-2025 Creative Diagnostics Announces Advanced Microbial Genome Editing Services to Accelerate Bio-research Creative Diagnostics
03-Jul-2025 Enthesopathy Treatment Market Set for Explosive Growth to $337.5 Billion by 2033 amid Surge in Biologics and Regenerative Therapies – A Report By Acumen Research And Consulting Acumen Research and Consulting
03-Jul-2025 Penicillin Active Pharmaceutical Ingredients Market to Reach USD 4.97 Billion by 2033, Fuelled by Rising Antibiotic Demand and Pharma R&D Boom - Says Acumen Research And Consulting Acumen Research and Consulting
02-Jul-2025 Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma Regeneron
02-Jul-2025 PHARMASEAL and Viedoc Announce a Technical Integration Partnership PHARMASEAL
02-Jul-2025 Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health Ebenbuild
01-Jul-2025 Burial Insurance Market Set to Exceed USD 534.8 Billion by 2033 with 6.9% CAGR – Acumen Research and Consulting Report Acumen Research and Consulting
30-Jun-2025 HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy HUTCHMED
30-Jun-2025 OncoZenge: Investor Receives State Administration of Foreign Exchange (SAFE) Approval OncoZenge:
30-Jun-2025 Insights from Exceptional Cancer Survivors: Cure51 Partners with French Bordeaux-based Contract research Organisation Explicyte to proceed with spatial analysis of exceptional Cancer survivors Samples from 40 Countries Cure51
30-Jun-2025 Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Riliprubart
30-Jun-2025 ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP ProQR
30-Jun-2025 Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs Stalicla
30-Jun-2025 STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer STORM Therapeutics
30-Jun-2025 Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations Tilray Medical
30-Jun-2025 UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency Disorder UCB
26-Jun-2025 Revolutionizing Clinical Trials: Evolution Summit 2025 Returns to San Diego Marcus Evans
25-Jun-2025 Revolutionizing Clinical Research: Evolution Summit 2025 to Bring Together Industry Pioneers in Montreux, Switzerland Marcus Evans
24-Jun-2025 New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine Lundbeck
24-Jun-2025 Phastar appoints Industry Veteran Billy Amzal as Head of Strategic Consulting Phastar